The quinolone family: from antibacterial to anticancer agents
C Sissi, M Palumbo - Current Medicinal Chemistry-Anti-Cancer …, 2003 - ingentaconnect.com
The present review focuses on the structural modifications responsible for the transformation
of an antibacterial into an anticancer agent. Indeed, a distinctive feature of drugs based on …
of an antibacterial into an anticancer agent. Indeed, a distinctive feature of drugs based on …
Quinone methides tethered to naphthalene diimides as selective G-quadruplex alkylating agents
…, C Bertipaglia, M Mella, C Sissi… - Journal of the …, 2009 - ACS Publications
We have developed novel G-quadruplex (G-4) ligand/alkylating hybrid structures, tethering
the naphthalene diimide moiety to quaternary ammonium salts of Mannich bases, as quinone…
the naphthalene diimide moiety to quaternary ammonium salts of Mannich bases, as quinone…
Spectroscopic, molecular modeling, and NMR-spectroscopic investigation of the binding mode of the natural alkaloids berberine and sanguinarine to human telomeric …
…, C Richter, HRA Jonker, K Saxena, C Sissi… - ACS chemical …, 2012 - ACS Publications
G-quadruplex structures can be formed at the single-stranded overhang of telomeric DNA,
and ligands able to stabilize this structure have recently been identified as potential …
and ligands able to stabilize this structure have recently been identified as potential …
Hybrid ligand–alkylating agents targeting telomeric G-quadruplex structures
…, L Germani, C Percivalle, C Sissi… - Organic & …, 2012 - pubs.rsc.org
The synthesis, physico-chemical properties and biological effects of a new class of naphthalene
diimides (NDIs) capable of reversibly binding telomeric DNA and alkylate it through an …
diimides (NDIs) capable of reversibly binding telomeric DNA and alkylate it through an …
Effects of magnesium and related divalent metal ions in topoisomerase structure and function
C Sissi, M Palumbo - Nucleic acids research, 2009 - academic.oup.com
The catalytic steps through which DNA topoisomerases produce their biological effects and
the interference of drug molecules with the enzyme–DNA cleavage complex have been …
the interference of drug molecules with the enzyme–DNA cleavage complex have been …
Nucleic acid aptamers based on the G-quadruplex structure: therapeutic and diagnostic potential
B Gatto, M Palumbo, C Sissi - Current medicinal chemistry, 2009 - ingentaconnect.com
Aptamers are short DNA- or RNA-based oligonucleotides selected from large combinatorial
pools of sequences for their capacity to efficiently recognize targets ranging from small …
pools of sequences for their capacity to efficiently recognize targets ranging from small …
Phosphate diester and DNA hydrolysis by a multivalent, nanoparticle-based catalyst
…, F Selvestrel, V Lombardo, C Sissi… - Journal of the …, 2008 - ACS Publications
… Claudia Sissi - Dipartimento di Scienze Chimiche and CNR-ITM, Università di Padova,
Padova, Italy, Dipartimento di Scienze Farmaceutiche, Università di Padova, Padova, Italy …
Padova, Italy, Dipartimento di Scienze Farmaceutiche, Università di Padova, Padova, Italy …
G-quadruplexes in human promoters: A challenge for therapeutic applications
Background G-rich sequences undergo unique structural equilibria to form G-quadruplexes (G4)
both in vitro and in cell systems. Several pathologies emerged to be directly related to …
both in vitro and in cell systems. Several pathologies emerged to be directly related to …
The evolving world of protein-G-quadruplex recognition: a medicinal chemist's perspective
C Sissi, B Gatto, M Palumbo - Biochimie, 2011 - Elsevier
The physiological and pharmacological role of nucleic acids structures folded into the non
canonical G-quadruplex conformation have recently emerged. Their activities are targeted at …
canonical G-quadruplex conformation have recently emerged. Their activities are targeted at …
Pt-based drugs: the spotlight will be on proteins
O Pinato, C Musetti, C Sissi - Metallomics, 2014 - academic.oup.com
Platinum-complexes represent some of the most successful groups of clinically used
anticancer drugs. Their mechanism of action relies on the formation of stable DNA adducts …
anticancer drugs. Their mechanism of action relies on the formation of stable DNA adducts …